Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML)

NCT01074047 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

488

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
DRUG: Conventional Care Regimen

Sponsor

Celgene